Touchlight, a biotechnology developing DNA-based genetic medicines, has appointed Karen Fallen as Chief Executive Officer of Touchlight DNA Services. Karen will apply her industry experience to further expand Touchlight’s contract manufacturing business, which is delivering GMP materials to third parties developing Covid-19 vaccines. Her responsibilities will include boosting manufacturing capacity and substantially extending the customer base globally. She joins the companyfrom Lonza, w...